EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease

Wen Li, Qiuping Chen iD, Chengjie Peng, Dan Yang iD, Si Liu, Yanwen Lv, Langqi Jiang, Shijun Xu, Lihua Huang iD

International Journal of Molecular Sciences · 05.01.2025 · 26 (1) · 403

DOI: 10.3390/ijms26010403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.01.2025. Verfasst von Wen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptor for Advanced Glycation End Products, Glycation End Products, Advanced. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, General Project of the Sichuan Provincial Administration of Traditional Chinese Medicine, Seventh Batch of National TCM Expert Academic Experience Inheritance Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Receptor for Advanced Glycation End Products (RAGE), part of the immunoglobulin superfamily, plays a significant role in various essential functions under both normal and pathological conditions, especially in the progression of Alzheimer’s disease (AD). RAGE engages with several damage-associated molecular patterns (DAMPs), including advanced glycation end products (AGEs), beta-amyloid peptide (Aβ), high mobility group box 1 (HMGB1), and S100 calcium-binding proteins. This interaction impairs the brain’s ability to clear Aβ, resulting in increased Aβ accumulation, neuronal injury, and mitochondrial dysfunction. This further promotes inflammatory responses and oxidative stress, ultimately leading to a range of age-related diseases. Given RAGE’s significant role in AD, inhibitors that target RAGE and its ligands hold promise as new strategies for treating AD, offering new possibilities for alleviating and treating this serious neurodegenerative disease. This article reviews the various pathogenic mechanisms of AD and summarizes the literature on the interaction between RAGE and its ligands in various AD-related pathological processes, with a particular focus on the evidence and mechanisms by which RAGE interactions with AGEs, HMGB1, Aβ, and S100 proteins induce cognitive impairment in AD. Furthermore, the article discusses the principles of action of RAGE inhibitors and inhibitors targeting RAGE-ligand interactions, along with relevant clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptor for Advanced Glycation End ProductsGlycation End Products, AdvancedHumansAnimalsLigandsHMGB1 ProteinAmyloid beta-Peptides

Stichwörter der Autor:innen

ADAGESAβHMGB1RAGES100

Substanzen

Receptor for Advanced Glycation End ProductsLigandsGlycation End Products, AdvancedHMGB1 ProteinAmyloid beta-Peptides

Autor:innen und Institutionen

  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu 611137, China.
  • Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

ORCID-Profile: Qiuping Chen, Dan Yang, Lihua Huang

Förderung

  • National Natural Science Foundation of China
  • General Project of the Sichuan Provincial Administration of Traditional Chinese Medicine
  • Seventh Batch of National TCM Expert Academic Experience Inheritance Project
  • Undergraduate Innovation and Entrepreneurship Program
  • Chengdu University of Traditional Chinese Medicine - Xinglin Scholar Program
  • Chengdu University of Traditional Chinese Medicine—Xinglin Scholar Program
  • Seventh Batch of the National TCM Expert Academic Experience Inheritance Project

Zitieren

APA

Li, W., Chen, Q., Peng, C., Yang, D., Liu, S., Lv, Y., Jiang, L., Xu, S., & Huang, L. (2025). Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease. International Journal of Molecular Sciences, 26(1), 403. https://doi.org/10.3390/ijms26010403

Vancouver

Li W, Chen Q, Peng C, Yang D, Liu S, Lv Y, et al. Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease. International Journal of Molecular Sciences. 2025;26(1):403. doi:10.3390/ijms26010403

BibTeX
@article{Li2025,
  author = {Li, Wen and Chen, Qiuping and Peng, Chengjie and Yang, Dan and Liu, Si and Lv, Yanwen and Jiang, Langqi and Xu, Shijun and Huang, Lihua},
  title = {Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {1},
  pages = {403},
  doi = {10.3390/ijms26010403}
}
Kostenlos starten →